🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

AnaptysBio, Inc.

ANAB Healthcare
$59.71 $-0.7 (-1.16%)
Market Cap: $1.74 B
Gurus Holding
7
Popularity Rank
#1024
% of Shares Held
0.95%
Net Activity (Q1 2026)
-$101.72 M

Guru Ownership Trend

Guru Analysis for AnaptysBio, Inc. (ANAB)

AnaptysBio, Inc. (ANAB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.43 M.

Top institutional holders include Renaissance Technologies (RenTech) and Ken Fisher.

Institutional sentiment is currently Bearish. This is evidenced by a $101.72 M net outflow during the quarter.

Recent activity highlights John Hussman who opened a new position. Conversely, Steven Cohen reduced exposure by 97.1%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q1 2026)

+$3.09 M
Total Buy Value
New Buys 2
Additions 3
-$104.82 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
2
Net Buyers
5

FAQs for AnaptysBio, Inc. (ANAB)

Major holders include Renaissance Technologies (RenTech) ($5.04 M), Ken Fisher ($3.14 M), Steven Cohen ($3.07 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 275,200 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $101.72 M, with 5 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ANAB. The total reported sell value was $104.82 M.

Yes, 2 managers opened new positions in ANAB, and 3 increased their existing holdings. The total reported buy value was $3.09 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Add 19.1% 90,900 $5.04 M Q1 2026
0.00% Add 0.1% 56,596 $3.14 M Q1 2026
0.00% Reduce -97.1% 55,303 $3.07 M Q1 2026
0.00% Add 23.4% 32,467 $1.8 M Q1 2026
0.25% New Buy 21,000 $1.16 M Q1 2026
0.00% New Buy 13,972 $774,887 Q1 2026
0.00% Reduce -71.3% 4,962 $275,193 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form